These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21620764)

  • 1. Cytomegalovirus quantification: where to next in optimising patient management?
    Atkinson C; Emery VC
    J Clin Virol; 2011 Aug; 51(4):223-8. PubMed ID: 21620764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
    Kamar N; Mengelle C; Yahyaoui S; Sandres-Sauné K; Durand D; Izopet J; Rostaing L
    J Clin Virol; 2005 May; 33(1):35-42. PubMed ID: 15797363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
    New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.
    Gouarin S; Vabret A; Gault E; Petitjean J; Regeasse A; Hurault de Ligny B; Freymuth F
    J Clin Virol; 2004 Mar; 29(3):194-201. PubMed ID: 14962789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy.
    Buyck HC; Griffiths PD; Emery VC
    J Clin Virol; 2010 Sep; 49(1):32-6. PubMed ID: 20667769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring transplant patients for human cytomegalovirus: Diagnostic update.
    Gerna G; Lilleri D
    Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact.
    Baldanti F; Gerna G
    J Antimicrob Chemother; 2003 Sep; 52(3):324-30. PubMed ID: 12888590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of real-time PCR for diagnosis and treatment of human cytomegalovirus infection in children.
    Chen FH; Samson KT; Chen H; Pan SN; He ZX; Iikura Y; Shioda S
    Pediatr Allergy Immunol; 2004 Jun; 15(3):210-5. PubMed ID: 15209952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus load measurement and its applications for pre-emptive therapy in patients undergoing hematopoietic stem cell transplantation.
    Baldanti F; Lilleri D; Gerna G
    Hematol Oncol; 2008 Sep; 26(3):123-30. PubMed ID: 18386849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of human cytomegalovirus infection by FQ-PCR technique and its application in the diagnosis and treatment of HCMV infected children].
    Chen F; He Z; Pan S; Ning F; Wang Q; Xiao Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):187-90. PubMed ID: 12196838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
    Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a quantitative-competitive PCR for quantification of human cytomegalovirus load and comparison with antigenaemia, viraemia and pp67 RNA detection by nucleic acid sequence-based amplification.
    Bergallo M; Costa C; Tarallo S; Daniele R; Merlino C; Segoloni GP; Negro Ponzi A; Cavallo R
    Panminerva Med; 2006 Jun; 48(2):119-27. PubMed ID: 16953149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
    Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C
    Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp65-antigen test in guiding pre-emptive antiviral treatment.
    Allice T; Cerutti F; Pittaluga F; Varetto S; Franchello A; Salizzoni M; Ghisetti V
    J Virol Methods; 2008 Mar; 148(1-2):9-16. PubMed ID: 18045702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saliva as a source of HCMV DNA in allogeneic stem cell transplantation patients.
    Correia-Silva JF; Bruna-Romero O; Resende RG; Miranda LP; Oliveira FE; Costa FO; Xavier SG; Figueiredo-Neves SP; Almeida HC; Bittencourt H; Gomez RS
    Oral Dis; 2010 Mar; 16(2):210-6. PubMed ID: 20374507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.
    Ziyaeyan M; Sabahi F; Alborzi A; Mahboudi F; Kazemnejad A; Ramzi M; Moravej A; Jaberi MM
    Exp Clin Transplant; 2006 Jun; 4(1):470-4. PubMed ID: 16827646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response.
    Lisboa LF; Asberg A; Kumar D; Pang X; Hartmann A; Preiksaitis JK; Pescovitz MD; Rollag H; Jardine AG; Humar A
    Transplantation; 2011 Jan; 91(2):231-6. PubMed ID: 21048530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of human cytomegalovirus infection in transplantation: validation of virologic cut-offs for preemptive therapy and immunological cut-offs for protection.
    Gerna G; Lilleri D; Furione M; Baldanti F
    New Microbiol; 2011 Jul; 34(3):229-54. PubMed ID: 21811744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter quality control study for human cytomegalovirus DNAemia quantification.
    Lilleri D; Lazzarotto T; Ghisetti V; Ravanini P; Capobianchi MR; Baldanti F; Gerna G;
    New Microbiol; 2009 Jul; 32(3):245-53. PubMed ID: 19845106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.